ROCKWELL MEDICAL, INC.

Rockwell Medical, Inc. develops, manufactures, commercializes, and distributes hemodialysis concentrates and dialysate products for end-stage kidney disease treatment. The company produces liquid and dry formulations of citric and acetic acid concentrates, bulk and individual bicarbonate powders, single-use bicarbonate cartridges, and dedicated dry acid mixing systems. In addition, it supplies ancillary hemodialysis items such as cleaning agents, descalers, and water softener salt pellets. These medical products serve freestanding outpatient clinics, hospital-based centers, skilled nursing facilities, and home healthcare settings. Rockwell Medical provides its portfolio directly to dialysis service organizations and through healthcare distributors.

The company operates manufacturing facilities in Michigan and Texas for hemodialysis concentrates, along with an equipment fabrication site in Iowa for dry acid mixers. It distributes products domestically using its internal transport fleet and third-party carriers, and serves international markets through external distribution partners. Its client base includes 294 customers across the United States as well as distributors reaching more than 30 countries. Corporate headquarters are situated in Wixom, Michigan.

Summary of the business section of Rockwell Medical's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, we had 157 employees, substantially all of whom are full time employees.”